您的位置：首页 > 产品中心 > 211096-49-0， SB265610
SB265610
产品别名
211096-49-0
SB265610
SB 265610
N-(2-Bromophenyl)-N′-(7-cyano-1H-benzotriazol-4-yl)urea
1-(2-Bromophenyl)-3-(4-cyano-1H-benzo[d] [1,2,3]triazol-7-yl)urea
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C14H9BrN6O |
| Molecular weight | 357.16 |
| MDL number | MFCD09971124 |
| PubChem Substance ID【PubChem化学物质编号】 | 329825416 |
| NACRES | NA.77 |
| Application【应用】 | SB265610 has been used:
|
| Biochem/physiol Actions【生化/生理作用】 | SB265610 is a potent and selective CXCR2 chemokine receptor antagonist. It has a Kd = 2.5 nM. |
| Features and Benefits【特点和优势】 | This compound is featured on the Chemokine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| color【颜色】 | white to light brown |
| solubility【溶解性】 | DMSO: 15 mg/mL, clear |
| storage temp.【储存温度】 | 2-8℃ |
| SMILES string | Brc1ccccc1NC(=O)Nc2ccc(C#N)c3nn[nH]c23 |
| InChI | 1S/C14H9BrN6O/c15-9-3-1-2-4-10(9)17-14(22)18-11-6-5-8(7-16)12-13(11)20-21-19-12/h1-6H,(H2,17,18,22)(H,19,20,21) |
| InChI key | SEDUMQWZEOMXSO-UHFFFAOYSA-N |
| packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral |
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
